2C-I - Erowid Exp - 'A Dangerous Drug'

A Dangerous Drug

2C-I

Citation: brown. "A Dangerous Drug: An Experience with 2C-I (exp36398)". Erowid.org. Sep 1, 2004. erowid.org/exp/36398

This report is in the Cellar.

Cellar reports contain important or useful pieces of information but otherwise fall
below the minimum readability or reliability standards expected of published reports
(or have significant other problems identified by the Erowid crew).

BODY WEIGHT:

230 lb

Last Mother's Day, myself and some others decided for a go on our first research chem, 2C-I. Doses were made by the halfing method, meaning I had obtained 200mg of the drug, and kept cutting it in half until I had obtained 8 approximate 25 mg doses. I do not have much to say about what is good about this drug, because after extended use, I was hospitalized for a heart attack, at 18. Use of the drug had been stopped for just over a week, and one night, while drinking and smoking some pot, the feeling just overwhelmed me. I would like to try and educate people so that they know that NO ONE is invincible. Playing with experimental drugs is in my opinion, more dangerous than playing with fire. My email is ryan_brown15@hotmail.com and I am willing to take as many emails as people are willing to send asking any questions regarding continuous health issues.

Exp Year: 2004	ExpID: 36398
Gender: Male
Age at time of experience: Not Given
Published: Sep 1, 2004	Views: 650
[ View PDF (to print) ] [ View LaTeX (for geeks) ] [ Swap Dark/Light ]
2C-I (172) : Health Problems (27), Not Applicable (38)

COPYRIGHTS: All reports copyright Erowid.
No AI Training use allowed without written permission.
TERMS OF USE: By accessing this page, you agree not to download, analyze, distill, reuse, digest, or feed into any AI-type system the report data without first contacting Erowid Center and receiving written permission.

Experience Reports are the writings and opinions of the authors who submit them. Some of the activities described are dangerous and/or illegal and none are recommended by Erowid Center.